The DOI matches its Crossref record, with a small difference in title or year; 54 of the 56 references it cites were found in a registry or an index.
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Open accessAbstract
CONTEXT: Antidepressant medications represent the best established treatment for major depressive disorder, but there is little evidence that they have a specific pharmacological effect relative to pill placebo for patients with less severe depression. OBJECTIVE: To estimate the relative benefit of medication vs placebo across a wide range of initial symptom severity in patients diagnosed with depression. DATA SOURCES: PubMed, PsycINFO, and the Cochrane Library databases were searched from January 1980 through March 2009, along with references from meta-analyses and reviews. STUDY SELECTION: Randomized placebo-controlled trials of antidepressants approved by the Food and Drug Administration in the treatment of major or minor depressive disorder were selected. Studies were included if their authors provided the requisite original data, they comprised adult outpatients, they included a medication vs placebo comparison for at least 6 weeks, they did not exclude patients on the basis of a placebo washout period, and they used the Hamilton Depression Rating Scale (HDRS). Data from 6 studies (718 patients) were included. DATA EXTRACTION: Individual patient-level data were obtained from study authors. RESULTS: Medication vs placebo differences varied substantially as a function of baseline severity. Among patients with HDRS scores below 23, Cohen d effect sizes for the difference between medication and placebo were estimated to be less than 0.20 (a standard definition of a small effect). Estimates of the magnitude of the superiority of medication over placebo increased with increases in baseline depression severity and crossed the threshold defined by the National Institute for Clinical Excellence for a clinically significant difference at a baseline HDRS score of 25. CONCLUSIONS: The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“antidepressants have been demonstrated efficient in treating MDD”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fournier and colleagues meta-analysed trials of selective serotonin reuptake inhibitors and estimated the effect size.45 For mild to severe depression the effect estimates ranged from -0.17 to -0.11; this is lower than the effect size for smoking cessation.”
From Change in mental health after smoking cessation: systematic review and meta-analysis (2014) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For SSRIs, researchers have argued that a substantial portion of the perceived therapeutic benefit in double-blind randomized clinical trials (RCTs) may stem from placebo responses rather than the drug itself (Sugarman et al., 2014; Fournier et al., 2010; Kirsch, 2014; Moncrieff and Kirsch, 2015).”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Fournier et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The introduction and widespread use of selective serotonine uptake inhibitors (SSRI) [22, 23] and psychological therapy including cognitive behavioral therapy (CBT) [24, 25] meant that well tolerated and effective treatments for depression and anxiety disorders became available in primary care, widening the group of individuals eligible for treatment.”
From Trends in psychiatric diagnoses, medications and psychological therapies in a large Swedish region: A population-based study (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“there are differences in individual response”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, the effect sizes are generally higher than those obtained for pharmacological treatment of mild-to-moderate depression [34]”
From One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial. (2020) · cites this paper as [34]
In the citing paper
“Two individual participant data meta-analysis (26, 27) indicated that patients with lower baseline severity would achieve smaller improvement compared to placebo.”
In the citing paper
“Individual-level meta-analyses have found a direct relationship between the magnitude of depressive symptoms and the effectiveness of antidepressants.8–10”
In the citing paper
“Thus, the benefits of antidepressants in non-severe depression have been argued to be minimal.8 11”
In the citing paper
“One small individual patient data meta-analysis found support for increasing benefit with increasing severity of depression,20 but three larger individual patient data meta-analyses did not find any such effect of antidepressants compared with placebo on depression severity .44–46”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [20]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“Although antidepressants are unlikely to be effective in most presentations of distress (18), physical activity, psychotherapeutic approaches, and discussions with diabetes team members can be effective.”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“The strength of the pooled standardised mean difference in change was clinically important - the association between smoking cessation and change in depression and anxiety was equal to or larger than the estimate from trials of antidepressants versus placebo.”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
In the citing paper
“A meta-analysis of individual-level data from randomised controlled trials (RCTs) of antidepressants for”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,421
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607
Self-citationOstwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148
Research works printed but not linked: 1
- [3]Depression Guideline Panel Depression in primary care: Vol. 2. Treatment of major depression Clinical Practice Guideline No. 5. AHCPR Publication No. 93-0551 Rockville, MD U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research 1993
Cited by
Sorted by citations
Items 501–600 of 1,006
Gaur, V., & Kumar, A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.004 · Cited by 44
Estimates of the Social Cost of Carbon: Background and Results from the RICE-2011 ModelPreprint
Nordhaus, W. D. (2011) · SSRN Electronic Journal · doi:10.2139/ssrn.1945844 · Cited by 90
Ayoughi, S., Missmahl, I., Weierstall, R., & Elbert, T. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-14 · Cited by 43
Commercial Interests and the Erosion of Trust in Science
Pinto, M. F. (2020) · Philosophy of Science · doi:10.1086/710521 · Cited by 50
Jiang, L., Zhang, S., Wang, Y., So, K., Ren, C., & Tao, Q. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.08.055 · Cited by 45
Morningness – eveningness and treatment response in major depressive disorder
Corruble, E., Frank, E., Gressier, F., Courtet, P., Bayle, F., Llorca, P., Vaïva, G., & Gorwood, P. A. P. M. (2013) · Chronobiology International · doi:10.3109/07420528.2013.834924 · Cited by 43
Gill, J. M., Klinkman, M. S., & Chen, Y. X. (2010) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2010.04.090299 · Cited by 44
Andrea, S. B., Siegel, S. A. R., & Teo, A. R. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.11.009 · Cited by 50
Network analysis of the genomic basis of the placebo effect
Wang, R., Hall, K. T., Giulianini, F., Passow, D., Kaptchuk, T. J., & Loscalzo, J. (2017) · JCI Insight · doi:10.1172/jci.insight.93911 · Cited by 43
Schröder, J., Berger, T., Meyer, B., Lutz, W., Späth, C., Michel, P., Rose, M., Hautzinger, M., Hohagen, F., Klein, J. P., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22727 · Cited by 43
Pramesona, B. A., & Taneepanichskul, S. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s162946 · Cited by 48
Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables
Perna, G., Alciati, A., Daccò, S., Grassi, M., & Caldirola, D. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0289 · Cited by 47
Volkmann, C., Volkmann, A., & Müller, C. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241497 · Cited by 42
Wand, T., Glover, S., & Paul, D. (2021) · International Journal of Mental Health Nursing · doi:10.1111/inm.12947 · Cited by 46
Bibliotherapy as a Treatment for Depression in Primary Care
Naylor, E. V., Antonuccio, D. O., Litt, M., Johnson, G. E., Spogen, D. R., Williams, R., McCarthy, C., Lu, M. M., Fiore, D. C., & Higgins, D. L. (2010) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-010-9207-2 · Cited by 43
Clinical experiences in conducting cognitive-behavioral therapy for social phobia
McAleavey, A. A., Castonguay, L. G., & Goldfried, M. R. (2014) · Behavior Therapy · doi:10.1016/j.beth.2013.09.008 · Cited by 42
Why I think antidepressants cause more harm than good
Gøtzsche, P. C. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70280-9 · Cited by 41
St. John's Wort for the Treatment of Psychiatric Disorders
Sarris, J. J. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.01.004 · Cited by 42
Cameron, I. M., Reid, I., & MacGillivray, S. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.078 · Cited by 44
Does recognition of depression in primary care affect outcome? The PREDICT-NL study
Kamphuis, M. H., Stegenga, B. T., Zuithoff, N. P. A., King, M., Nazareth, I., de Wit, N. J., & Geerlings, M. I. (2011) · Family Practice · doi:10.1093/fampra/cmr049 · Cited by 41
Depression, anxiety, and stress in patients with coronary heart disease
Fi, B. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh2017898104-109 · Cited by 42
Lorenzo‐Luaces, L., Zimmerman, M. A., & Cuijpers, P. J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.066 · Cited by 42
Goh, K. K., Chen, C.-H., Chiu, Y.-H., & Lu, M.-L. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119844199 · Cited by 44
Hang, X., Zhang, Y., Li, J., Li, Z., Zhang, Y., Ye, X., Tang, Q., & Sun, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.691200 · Cited by 44
Psychological Co-morbidities of Physical Illness
Pagoto, S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0029-6 · Cited by 44
Paris, J., & Phillips, J. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6504-1 · Cited by 44
Qiu, H., Liang, K., Lu, L., Gao, Y., Li, H., Hu, X., Xing, H., Huang, X., & Gong, Q. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.060 · Cited by 41
Correa, K. A., Liu, H., & Shankman, S. A. (2019) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2019.01.001 · Cited by 37
Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition
Lüscher, B., Feng, M., & Jefferson, S. J. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.03.002 · Cited by 41
Narayan, G. A., Hill, K., Wengler, K., He, X., Wang, J., Yang, J., Parsey, R. V., & DeLorenzo, C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01730-4 · Cited by 43
Papakostas, G. I., Fan, H., & Tedeschini, E. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.009 · Cited by 43
Dang, C., Wang, Q., Li, Q., Xiong, Y., & Lu, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1295564 · Cited by 40
Dose‐response relationship between depressive symptoms and hospital readmission
Cancino, R. S., Culpepper, L., Sadikova, E., Martin, J., Jack, B. W., & Mitchell, S. E. (2014) · Journal of Hospital Medicine · doi:10.1002/jhm.2180 · Cited by 40
Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression
Isacsson, G., & Adler, M. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01815.x · Cited by 41
The Efficacy of Psychotherapy: Focus on Psychodynamic Psychotherapy as an Example
Levy, K. N., Ehrenthal, J. C., Yeomans, F. E., & Caligor, E. (2014) · Psychodynamic Psychiatry · doi:10.1521/pdps.2014.42.3.377 · Cited by 40
Zilcha‐Mano, S., Dinger, U., McCarthy, K. S., Barrett, M. S., & Barber, J. P. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.015 · Cited by 40
The fibrinolytic system: A new target for treatment of depression with psychedelics
Idell, R. D., Florova, G., Komissarov, A. A., Shetty, S., Girard, R., & Idell, S. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.01.013 · Cited by 40
Caspani, G., Turecki, G., Lam, R. W. M., Milev, R. V., Frey, B. N., MacQUEEN, G. M., Müller, D. J., Rotzinger, S., Kennedy, S. H., Foster, J. A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02421-6 · Cited by 42
Preventing late-life depression: a clinical update
Baldwin, R. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210000864 · Cited by 40
Brimelow, R. E., Thangavelu, K., Beattie, R., & Dissanayaka, N. N. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.07.026 · Cited by 38
Mental Illness — Comprehensive Evaluation or Checklist?
McHugh, P. R., & Slavney, P. R. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1202555 · Cited by 39
Webb, C. A., Beard, C., Auerbach, R. P., Menninger, E., & Björgvinsson, T. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.07.015 · Cited by 38
Mansouri, M. T., Naghizadeh, B., Ghorbanzadeh, B., Alboghobeish, S., Amirgholami, N., Houshmand, G., & Cauli, O. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.02.009 · Cited by 39
Single-case experimental research designs.
Kazdin, A. E. (2015) · Methodological issues and strategies in clinical research (4th ed.). · doi:10.1037/14805-029 · Cited by 39
Esbitt, S. A., Tanenbaum, M. L., & Gonzalez, J. S. (2012) · Springer eBooks · doi:10.1007/978-0-85729-751-8_2 · Cited by 43
Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample
Takayanagi, Y., Spira, A. P., Bienvenu, O. J., Hock, R. S., Carras, M. C., Eaton, W. W., & Mojtabai, R. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08824 · Cited by 40
Mavandadi, S., Benson, A., DiFilippo, S. D., Streim, J. E., & Oslin, D. W. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2157 · Cited by 39
Dyadic Behavior Analysis in Depression Severity Assessment Interviews
Scherer, S. J., Hammal, Z., Yang, Y., Morency, L., & Cohn, J. F. (2014) · INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION · doi:10.1145/2663204.2663238 · Cited by 40
Golden, S. H., Shah, N. G., Naqibuddin, M., Payne, J. L., Hill‐Briggs, F., Wand, G. S., Wang, N., Langan, S. J., & Lyketsos, C. G. (2016) · Psychosomatics · doi:10.1016/j.psym.2016.08.003 · Cited by 43
Adult Missing Persons: Can an Investigative Framework be Generated Using Behavioural Themes?
Bonny, E. J., Almond, L., & Woolnough, P. S. (2016) · Journal of Investigative Psychology and Offender Profiling · doi:10.1002/jip.1459 · Cited by 46
Gu, Z., Zhou, A., Xiao, Y., Zhang, Q., & Li, J. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.063 · Cited by 39
Moncrieff, J. (2018) · BJPsych Bulletin · doi:10.1192/bjb.2017.11 · Cited by 40
Hase, M., Plagge, J., Hase, A., Braas, R., Ostacoli, L., Hofmann, A., & Huchzermeier, C. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01384 · Cited by 41
Insomnia and Susceptibility to Depressive Symptoms and Fatigue in Diverse Breast Cancer Survivors
Haque, R., Hsu, J. Y., Avila, C. C., Olmstead, R., Carroll, J., & Irwin, M. R. (2020) · Journal of Women s Health · doi:10.1089/jwh.2019.8135 · Cited by 44
Evidenzbasierte Therapie der Depression
Härter, M. C., Klesse, C., Bermejo, I., Bschor, T., Gensichen, J., Harfst, T., Hautzinger, M., Kolada, C., Kopp, I., Kühner, C., et al. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-3084-7 · Cited by 42
Nakajima, S., Uchida, H., Suzuki, T., Watanabe, K., Hirano, J., Yagihashi, T., Takeuchi, H., Abe, T., Kashima, H., & Mimura, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.08.008 · Cited by 39
Radović, A., Farris, C. A., Reynolds, K. A., Reis, E. C., Miller, E. P., & Stein, B. D. (2013) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000008 · Cited by 39
Bosker, F. J., Tanke, M. A. C., Jongsma, M. E., Cremers, T. I. F. H., Jagtman, E., Pietersen, C. Y., van der Hart, M. G. C., Gladkevich, A. V., Kema, I. P., & Westerink, B. H. C. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.001 · Cited by 37
Revisiting the drug interaction between tamoxifen and SSRI antidepressants
Juurlink, D. N. (2016) · BMJ · doi:10.1136/bmj.i5309 · Cited by 39
Morgan, A. J., Jorm, A. F., & Reavley, N. J. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413490035 · Cited by 37
Empirically supported use of psychiatric medications in adolescents and adults with IBD
Thorkelson, G., Bielefeldt, K., & Szigethy, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000734 · Cited by 39
The Economics of Treatment for Depression
Stecher, C. D., Cloonan, S., & Domino, M. E. (2023) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-061022-040533 · Cited by 43
Meng, X., & D’Arcy, C. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.11.014 · Cited by 40
Bschor, T., & Kilarski, L. L. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1155985 · Cited by 43
Jeon, W. J., Dean, B., Scarr, E., & Gibbons, A. S. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150612230045 · Cited by 38
The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer’s Disease Subjects
An, H., Choi, B., Park, K. W., Kim, D., Yang, D. W., Hong, C. H., Kim, S. Y., & Han, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160225 · Cited by 39
Structural abnormality of the hippocampus associated with depressive symptoms in heart failure rats
Suzuki, H., Sumiyoshi, A., Matsumoto, Y., Duffy, B. A., Yoshikawa, T., Lythgoe, M. F., Yanai, K., Taki, Y., Kawashima, R., & Shimokawa, H. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2014.10.040 · Cited by 35
Mangoo, S., Erridge, S., Holvey, C., Coomber, R., Barros, D. A. R., Bhoskar, U., Mwimba, G., Praveen, K., Symeon, C., Sachdeva-Mohan, S., et al. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2161894 · Cited by 35
Swanson, S. A., Hernández–Dı́az, S., Palmsten, K. K., Mogun, H., Olfson, M., & Huybrechts, K. F. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3798 · Cited by 37
Morgan, A. J., Reavley, N. J., & Jorm, A. F. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413512686 · Cited by 37
A quantitative review on outcome-to-antidepressants in melancholic unipolar depression
Valerio, M. P., Szmulewicz, A., & Martino, D. J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.088 · Cited by 37
Ermers, N. J., Hagoort, K., & Scheepers, F. E. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00472 · Cited by 41
New Molecular Targets for Antidepressant Drugs
Kornhuber, J., & Gulbins, E. (2021) · Pharmaceuticals · doi:10.3390/ph14090894 · Cited by 37
Konstantinidis, A., Papageorgiou, K., Grohmann, R., Horvath, A., Engel, R. R., & Kasper, S. F. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000745 · Cited by 37
Placebo effect in child and adolescent psychiatric trials.
Parellada, M., Moreno, C., Moreno, M., Espliego, A., de Portugal, E., & Arango, C. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.007 · Cited by 43
Jani, B., McLean, G., Nicholl, B. I., Barry, S., Sattar, N. A., Mair, F. S., & Cavanagh, J. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00018 · Cited by 39
‘They won't do any harm and might do some good’: time to think again on the use of antidepressants?
Middleton, H., & Moncrieff, J. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x548983 · Cited by 36
Affective Biases in Humans and Animals
Robinson, E. S. J., & Roiser, J. P. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_5011 · Cited by 37
Measuring mental health in humanitarian crises: a practitioner’s guide to validity
Kohrt, B. A., & Kaiser, B. N. (2021) · Conflict and Health · doi:10.1186/s13031-021-00408-y · Cited by 37
Angelucci, M., & Bennett, D. (2023) · American Economic Review · doi:10.1257/aer.20210687 · Cited by 53
Chemoenzymatic asymmetric synthesis of fluoxetine, atomoxetine, nisoxetine, and duloxetine
Rej, R. K., Das, T., Hazra, S., & Nanda, S. (2013) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2013.06.003 · Cited by 36
Weitz, E. S., Kleiboer, A. M., van Straten, A., Hollon, S. D., & Cuijpers, P. J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013478 · Cited by 36
Self-citationCasey, P., Cowan, P. A., Cowan, C. P., Draper, L., Mwamba, N., & Hewison, D. (2017) · Family Process · doi:10.1111/famp.12289 · Cited by 37
Kim, Y. R., Park, B.-K., Kim, Y. H., Shim, I., Kang, I., & Lee, M. Y. (2018) · BioMed Research International · doi:10.1155/2018/8249563 · Cited by 37
Serotonergic regulation of energy metabolism in peripheral tissues
Choi, W., Moon, J. H., & Kim, H. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0546 · Cited by 40
Zhang, X., & Belsky, J. (2020) · Development and Psychopathology · doi:10.1017/s0954579420000966 · Cited by 44
Xia, C.-X., Gao, X., Zhu, K. Y., Dong, T. T.-X., & Tsim, K. W. K. (2023) · Food & Function · doi:10.1039/d3fo01332d · Cited by 37
Roman, M. W. (2012) · Issues in Mental Health Nursing · doi:10.3109/01612840.2012.713447 · Cited by 36
Positive Activity Interventions for Mental Health Conditions
Shin, L. J., & Lyubomirsky, S. (2016) · Wiley eBooks · doi:10.1002/9781118468197.ch23 · Cited by 36
Treatment Selection in Depression: The Role of Clinical Judgment
Tomba, E., & Fava, G. A. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.003 · Cited by 35
Berlim, M. T., McGirr, A., Beaulieu, M.-M., Van den Eynde, F., & Turecki, G. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.029 · Cited by 38
Čihařová, M., Karyotaki, E., Miguel, C., Walsh, E., de Ponti, N., Amarnath, A., van Ballegooijen, W., Riper, H. M., Arroll, B., & Cuijpers, P. J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.070 · Cited by 36
Positive Psychology Interventions: A Review for Counselling Practitioners
Lambert, L., Emirates, A., Pasha-Zaidi, N., & Emirates, U. A. (2014) · Canadian Journal of Counselling and Psychotherapy · Cited by 55
Wiechers, I. R., Kirwin, P. D., & Rosenheck, R. A. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.10.007 · Cited by 35
Su, K. (2015) · Biomedicine · doi:10.7603/s40681-015-0021-x · Cited by 38
Prevalence and treatment of common mental disorders in the English national population, 1993–2007
Spiers, N. A., Qassem, T., Bebbington, P., McManus, S., King, M., Jenkins, R., Meltzer, H., & Brugha, T. S. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.174979 · Cited by 38
Zhao, Y., Lin, Z., Chen, L., Ouyang, L., Gu, L., Chen, F., & Zhang, Q. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.011 · Cited by 37
Mental Health in the Family Business: A Conceptual Model and a Research Agenda
Miller, D., Wiklund, J., & Yu, W. (2019) · Entrepreneurship Theory and Practice · doi:10.1177/1042258719837987 · Cited by 37
Hieronymus, F., Lisinski, A., Eriksson, E., & Østergaard, S. D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01364-0 · Cited by 35
Nashed, M. G., Seidlitz, E. P., Frey, B. N., & Singh, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.040 · Cited by 37
Metadata
- Authors
- Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J.
- Affiliations
- University of Pennsylvania (US)
- University of New Mexico (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-01-06
- Volume
- 303
- Issue
- 1
- Pages
- 47
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3712503
- OpenAlex
- W2004762037
- Cited by
- 2,009
- References
- 56
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 89 · 2023: 70 · 2022: 81 · 2021: 134 · 2020: 81 · 2019: 111 · 2018: 143 · 2017: 128 · 2016: 112 · 2015: 149 · 2014: 154 · 2013: 170 · 2012: 172
- FWCI
- 144.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- National Alliance for Research on Schizophrenia and Depression
- Universiteit Maastricht
- National Institute of Mental Health (K24MH001741, R10 MH50129, R01MH060998, K02MH001697, R10MH055875, R10MH055877)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, major depressive disorder, depression severity, placebo response, Hamilton Depression Rating Scale, treatment effect heterogeneity, mild depression, antidepressant efficacy
- MeSH terms
- Adult, Antidepressive Agents, Depression, Major Depressive Disorder, Humans, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
